The Study of Different Dose Rituximab in the Treatment of ITP

Clinical trial NCT03258866 · COMPLETED

Trial details

NCT number: NCT03258866
Sponsor: Shandong University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Purpura, Thrombocytopenic, Idiopathic Immune Thrombocytopenia

Start date: 2010-01-01
Primary completion: 2015-12-31
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.